𝔖 Bobbio Scriptorium

✦ LIBER ✦

Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event

✍ Scribed by Yongjun Wang; S. Claiborne Johnston

Book ID: 116192162
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 363 KB
Volume: 160
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2010.05.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Outcomes of Patients With Diabe

Clinical Outcomes of Patients With Diabetic Nephropathy Randomized to Clopidogrel Plus Aspirin Versus Aspirin Alone (A post hoc Analysis of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance [CHARISMA] Trial)

✍ Arijit Dasgupta; Steven R. Steinhubl; Deepak L. Bhatt; Peter B. Berger; Mingyuan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 369 KB

Rationale, design, and baseline data of

Rationale, design, and baseline data of the Japanese Primary Prevention Project (JPPP)—A randomized, open-label, controlled trial of aspirin versus no aspirin in patients with multiple risk factors for vascular events

✍ Tamio Teramoto; Kazuyuki Shimada; Shinichiro Uchiyama; Masahiro Sugawara; Yoshio 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 418 KB

Effects of aspirin plus extended-release

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study

✍ Hans-Christoph Diener; Ralph L Sacco; Salim Yusuf; Daniel Cotton; Stephanie Ôunp 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 191 KB

Rationale and design of the dual antipla

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions

✍ Laura Mauri; Dean J. Kereiakes; Sharon-Lise T. Normand; Stephen D. Wiviott; Davi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB